Physician profile
Alan Berger
NPI 1104861350
$18,952.55
in general payments reported to CMS, 2019-2025
26 companies · $1,575 in 2025
The $1,575 reported for 2025 was more than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,100 · 2020: $3,090 · 2021: $3,177 · 2022: $5,498 · 2023: $1,185 · 2024: $2,328 · 2025: $1,575.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $3,916 · Food and Beverage: $1,161 · Travel and Lodging: $10.72.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $3,916.00 |
| Food and Beverage | $1,160.51 |
| Travel and Lodging | $10.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $3,151.23 | 2019-2024 | |
| Abbott Laboratories | $3,061.54 | 2021-2024 | Xience Skypoint, Diamondback Peripheral, Jeti |
| Terumo Medical Corporation | $3,018.54 | 2019-2022 | |
| Medtronic Vascular, INC. | $2,197.79 | 2019-2020 | |
| Becton, Dickinson and Company | $2,025.00 | 2019-2024 | |
| Medtronic, INC. | $1,220.41 | 2020-2025 | Onyx Frontier |
| Zoll Medical Corporation | $1,100.00 | 2019-2020 | |
| Kestra Medical Technology Services, INC. | $607.18 | 2025 | Assure Wcd |
| Analog Devices INC. | $453.00 | 2025 | |
| Inari Medical, INC. | $440.72 | 2022 | |
| Cipla USA INC. | $413.00 | 2025 | |
| Covidien Lp | $280.00 | 2019 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $238.14 | 2019-2024 | Lifevest |
| Biotronik INC. | $148.73 | 2019-2024 | Orsiro Mission, Pantera Leo, Trapit |
| Chiesi USA, INC. | $135.15 | 2019 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abiomed | $113.68 | 2024-2025 | Impella |
| Bard Peripheral Vascular, INC. | $78.34 | 2022 | |
| Edwards Lifesciences Corporation | $73.15 | 2021 | |
| Penumbra, INC. | $50.93 | 2020-2023 | Indigo System |
| Heartflow, INC. | $39.27 | 2021 | |
| Otsuka America Pharmaceutical, INC. | $26.32 | 2024 | Rexulti |
| Boehringer Ingelheim Pharmaceuticals, INC. | $24.14 | 2024 | Jardiance |
| Bayer Healthcare Pharmaceuticals INC. | $15.72 | 2019 | |
| Opsens INC. | $15.12 | 2019 | |
| Janssen Pharmaceuticals, INC | $13.00 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $12.45 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alan Berger listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.